US Names India in Tariff Probe — Trade Deal Talks Face New Pressure

The United States Trade Representative has formally included India in its latest Section 301 investigation findings, proposing additional tariffs that could reshape bilateral trade flows. The move arrives as both nations attempt to negotiate a broader trade agreement, putting months of diplomatic groundwork at risk. For Indian businesses exporting everything from pharmaceuticals to agricultural products, the announcement signals fresh uncertainty heading into critical negotiations.

What the Section 301 Findings Say

The USTR released its findings this week, identifying India's trade practices as worthy of further action under the same legal mechanism used to justify sweeping tariffs on Chinese goods. Section 301 allows the US to impose penalties on countries deemed to be engaging in unfair trade practices. The investigation targets a range of sectors where American officials claim Indian policies disadvantage US companies. Officials in New Delhi quickly pushed back, calling the findings disproportionate and unhelpful ahead of planned talks.

The proposed duties would affect goods currently exempt from earlier rounds of American tariffs. Trade analysts in Mumbai say the list covers several major Indian export categories, though exact figures remain under discussion. The USTR has given a window for public comments before any final determination, a process that typically runs for several weeks.

Trade Deal Talks Now on Shaky Ground

Both governments had been working toward a limited trade pact that might ease tensions and boost commercial ties. American officials have pushed for greater market access for US financial services and agricultural exports, while India has sought relief from existing steel and aluminium duties. The Section 301 move complicates those conversations significantly.

Negotiators were already struggling to find common ground on pharmaceutical pricing and medical device tariffs. The new threat adds another layer of complexity that neither side anticipated when talks began. Commerce ministry officials in New Delhi declined to comment publicly on whether negotiations would continue as scheduled.

Impact on Indian Exporters and Workers

For manufacturers in states like Gujarat and Tamil Nadu, the prospect of new American tariffs creates immediate planning challenges. Many factories have ramped up production specifically for the US market, betting that a trade deal would open doors rather than close them. If duties take effect, those investments could become suddenly unprofitable.

The pharmaceutical sector faces particular scrutiny. India supplies nearly 40 percent of generic drugs consumed in the United States, making any tariff escalation a potential public health concern. Industry executives in Hyderabad have urged both governments to find a resolution before the situation escalates further. Workers in textile hubs across Punjab and Andhra Pradesh also watch nervously, knowing that American consumers buy a significant share of their output.

Government Response in New Delhi

The Indian commerce ministry released a statement calling the Section 301 findings disappointing but not unexpected. Officials indicated they would participate fully in the comment period and continue engaging with their American counterparts. The statement stopped short of announcing any retaliatory measures, choosing instead to emphasise India's commitment to fair trade practices.

Trade experts at the Indian Institute of Foreign Trade in Delhi say New Delhi has limited options for response. India already faces roughly $6 billion in annual tariffs from earlier American actions. Adding more duties on American goods could further strain relations without guaranteeing relief from the new proposals.

What Comes Next

The public comment period will run through the coming weeks, giving Indian industry groups time to lobby against specific tariff line items. American businesses with interests in India will also submit testimony, creating a complex picture for policymakers on both sides. Final recommendations from the USTR typically follow within 60 to 90 days of the comment period's close.

Watch for whether scheduled trade talks proceed as planned or get postponed in the wake of this development. Indian exporters should monitor the Federal Register for updates on which product categories face the steepest proposed rates. The outcome will shape commercial ties between the world's two largest democracies for years to come.